NASDAQ:UPB

Upstream Bio Stock Forecast

etoro logo Buy UPB
*Your capital is at risk
$7.43
-0.200 (-2.62%)
At Close: Jun 04, 2026
AI Analysis AI Analysis of UPB AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add UPB to Watchlist?
Some Reasons Why To Add UPB:
  • High gross margin of 98.5%
  • Low bankruptcy risk (Altman Z-Score: 14.97)
  • Highly efficient cash conversion (100% FCF/OCF ratio)
PDF

Red day on Thursday for Upstream Bio, Inc.
(Updated on Jun 04, 2026)

Sell candidate since May 29, 2026 Loss -11.12%

The Upstream Bio, Inc. stock price fell by -2.62% on the last day (Thursday, 4th Jun 2026) from $7.63 to $7.43. During the last trading day the stock fluctuated 6.22% from a day low at $7.31 to a day high of $7.77. The price has been going up and down for this period, and there has been a -11.65% loss for the last 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -64 thousand shares and in total, 601 thousand shares were bought and sold for approximately $4.47 million.

The stock lies in the lower of a very wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $7.23 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -6.58% during the next 3 months and, with a 90% probability hold a price between $6.75 and $9.40 at the end of this 3-month period.

UPB Signals & Forecast

A buy signal was issued from a pivot bottom point on Tuesday, June 02, 2026, and so far it has risen 2.48%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Upstream Bio, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $7.90 and $8.88. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Support, Risk & Stop-loss for Upstream Bio, Inc. stock

Upstream Bio, Inc. finds support from accumulated volume at $7.25 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.455 between high and low, or 6.22%. For the last week, the stock has had daily average volatility of 7.05%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (UPB) For The Upcoming Trading Day Of Friday 5th

For the upcoming trading day on Friday, 5th we expect Upstream Bio, Inc. to open at $7.50, and during the day (based on 14 day Average True Range), to move between $7.17 and $7.69, which gives a possible trading interval of +/-$0.525 (+/-7.32%) up or down from last closing price. If Upstream Bio, Inc. takes out the full calculated possible swing range there will be an estimated 7.32% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $7.25 (2.42%) than the resistance at $8.45 (13.73%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Upstream Bio, Inc. stock A Buy?

Upstream Bio, Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -2.882 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on June 5, 2026 - $7.50 ( 0.96%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

UPB Performance

Trading levels for UPB

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 7.96 7.09%
R2 7.78 4.75%
R1 7.68 3.30%
Price 7.43
S1 7.33 -1.37%
S2 7.22 -2.82%
S3 7.05 -5.16%

Accumulated Volume Support & Resistance Levels

Level Price
R3 9.09 22.34%
R2 8.67 16.69%
R1 8.45 13.73%
Price 7.43
S1 7.25 -2.42%
S2 0 -
S3 0 -

FAQ

What is the symbol for Upstream Bio, Inc. Stock and on which exchange is it traded?
The symbol for Upstream Bio, Inc. is UPB and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Upstream Bio, Inc. Stock?
Upstream Bio, Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

How to buy Upstream Bio, Inc. Stock?
Upstream Bio, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Upstream Bio, Inc. Stock.

What's the current price of Upstream Bio, Inc. Stock?
As of the end of day on the Jun 04, 2026, the price of an Upstream Bio, Inc. (UPB) share was $7.43.

What is the 52-week high and low for Upstream Bio, Inc. Stock?
The 52-week high for Upstream Bio, Inc. Stock is $33.68 and the 52-week low is $7.19.

What is the market capitalization of Upstream Bio, Inc. Stock?
As of the Jun 04, 2026, the market capitalization of Upstream Bio, Inc. is 404.34M.

When is the next earnings date for Upstream Bio, Inc.?
The upcoming earnings date for Upstream Bio, Inc. is Aug 05, 2026.
Click to get the best stock tips daily for free!
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
4.43% Jun 01
N
NVRI
$19.53
0.87% May 20
RUN
$12.83
15.51% May 06
GLBE
$31.61
4.05% May 05
SAP
$172.39
8.56% May 05

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE